Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for postoperative body fluid management after open heart surgery
jRCTs051230072Active, not recruiting
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tolvaptan in hypervolemia and complications of surgical procedures (2 arms). Primary endpoint: Cumulative urine volume 1-2 days after surgery. Started Oct 2023; status: active, not recruiting.
02
Drugs
tolvaptan
03
Conditions
hypervolemiacomplications of surgical procedures
Beyond the preview
Go deeper on jRCTs051230072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051230072.